Illumina's Promising Growth Trajectory: Buy Rating Backed by Strategic Positioning and Market Innovations
Bernstein Maintains Illumina(ILMN.US) With Hold Rating
BofA Securities Maintains Illumina(ILMN.US) With Sell Rating, Maintains Target Price $120
Bernstein Maintains Illumina(ILMN.US) With Hold Rating
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
Illumina Is Maintained at Equal-Weight by Morgan Stanley
Illumina Analyst Ratings
Morgan Stanley Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $150
Bernstein Maintains Illumina(ILMN.US) With Hold Rating, Raises Target Price to $140
Evercore Maintains Illumina(ILMN.US) With Buy Rating, Raises Target Price to $180
Citi Maintains Illumina(ILMN.US) With Hold Rating
Illumina Analyst Ratings
Citi Downgrades Illumina(ILMN.US) to Hold Rating, Cuts Target Price to $165
RBC Trims Price Target on Illumina to $252 From $254, Keeps Outperform Rating
Citi Maintains Illumina(ILMN.US) With Buy Rating, Maintains Target Price $190
Stephens Maintains Illumina(ILMN.US) With Buy Rating, Raises Target Price to $184
Morgan Stanley Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $156
Illumina Is Maintained at Overweight by Piper Sandler
Illumina Analyst Ratings
Piper Sandler Maintains Illumina(ILMN.US) With Buy Rating, Cuts Target Price to $185